WallStSmart

Micron Technology Inc (MU)vsResMed Inc (RMD)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Micron Technology Inc generates 949% more annual revenue ($58.12B vs $5.54B). MU leads profitability with a 41.5% profit margin vs 27.4%. MU appears more attractively valued with a PEG of 0.20. MU earns a higher WallStSmart Score of 80/100 (A-).

MU

Exceptional Buy

80

out of 100

Grade: A-

Growth: 8.7Profit: 10.0Value: 6.3Quality: 8.5
Piotroski: 4/9Altman Z: 3.06

RMD

Strong Buy

73

out of 100

Grade: B

Growth: 6.7Profit: 9.5Value: 5.3Quality: 8.3
Piotroski: 6/9Altman Z: 4.34
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for MU.

RMDOvervalued (-13.1%)

Margin of Safety

-13.1%

Fair Value

$229.58

Current Price

$206.76

$22.82 premium

UndervaluedFair: $229.58Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MU6 strengths · Avg: 10.0/10
Market CapQuality
$729.23B10/10

Mega-cap, among the largest globally

PEG RatioValuation
0.2010/10

Growing faster than its price suggests

Return on EquityProfitability
39.8%10/10

Every $100 of equity generates 40 in profit

Profit MarginProfitability
41.5%10/10

Keeps 42 of every $100 in revenue as profit

Operating MarginProfitability
67.6%10/10

Strong operational efficiency at 67.6%

Revenue GrowthGrowth
196.3%10/10

Revenue surging 196.3% year-over-year

RMD4 strengths · Avg: 9.5/10
Operating MarginProfitability
35.3%10/10

Strong operational efficiency at 35.3%

Altman Z-ScoreHealth
4.3410/10

Safe zone — low bankruptcy risk

Return on EquityProfitability
25.3%9/10

Every $100 of equity generates 25 in profit

Profit MarginProfitability
27.4%9/10

Keeps 27 of every $100 in revenue as profit

Areas to Watch

MU2 concerns · Avg: 4.0/10
P/E RatioValuation
30.5x4/10

Premium valuation, high expectations priced in

Price/BookValuation
11.6x4/10

Trading at 11.6x book value

RMD0 concerns · Avg: 0/10

No major concerns identified

Comparative Analysis Report

WallStSmart Research

Bull Case : MU

The strongest argument for MU centers on Market Cap, PEG Ratio, Return on Equity. Profitability is solid with margins at 41.5% and operating margin at 67.6%. Revenue growth of 196.3% demonstrates continued momentum.

Bull Case : RMD

The strongest argument for RMD centers on Operating Margin, Altman Z-Score, Return on Equity. Profitability is solid with margins at 27.4% and operating margin at 35.3%. Revenue growth of 10.8% demonstrates continued momentum.

Bear Case : MU

The primary concerns for MU are P/E Ratio, Price/Book.

Bear Case : RMD

No major red flags identified for RMD, but monitor valuation.

Key Dynamics to Monitor

MU profiles as a growth stock while RMD is a mature play — different risk/reward profiles.

MU carries more volatility with a beta of 1.92 — expect wider price swings.

MU is growing revenue faster at 196.3% — sustainability is the question.

MU generates stronger free cash flow (6.5B), providing more financial flexibility.

Bottom Line

MU scores higher overall (80/100 vs 73/100), backed by strong 41.5% margins and 196.3% revenue growth. Both earn "Exceptional Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Micron Technology Inc

TECHNOLOGY · SEMICONDUCTORS · USA

Micron Technology, Inc. is an American producer of computer memory and computer data storage including dynamic random-access memory, flash memory, and USB flash drives. It is headquartered in Boise, Idaho.

Visit Website →

ResMed Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions.

Visit Website →

Want to dig deeper into these stocks?